Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2185379 | 0.81 | TSHR (0.44) | TSHR | |
| SCHEMBL6545810 | 0.78 | — | — | |
| SCHEMBL5838116 | 0.75 | TSHR (0.50) | TSHR | |
| SCHEMBL475948 | 0.67 | ALDH1A1 (0.39) | — | |
| SCHEMBL475947 | 0.66 | LMNA (0.32) | — | |
| SCHEMBL21462897 | 0.65 | TSHR (0.46) | TSHR | |
| SCHEMBL28918750 | 0.64 | CES1 (0.39) | TSHR | |
| SCHEMBL6545875 | 0.63 | LMNA (0.40) | TSHR | |
| SCHEMBL22974962 | 0.63 | TSHR (0.43) | TSHR | |
| SCHEMBL5837982 | 0.62 | TSHR (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040236130-A1 | Process for the preparation of trialkylsilated carboxylate monomers, the obatined trialkylsilated carboxylate monomers and their use in anti-fouling coatings | SIGMA COATINGS B.V. (NL) | 2004-11-25 | — | — | US | disclosed |
| EP-1389214-A1 | PROCESS FOR THE PREPARATION OF TRIALKYLSILYLATED CARBOXYLATE MONOMERS, THE OBTAINED TRIALKYLSILYLATED CARBOXYLATE MONOMERS AND THEIR USE IN ANTI-FOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2004-02-18 | — | — | EP | disclosed |
| EP-1295888-A1 | Process for the preparation of trialkylsilylated carboxylate monomers, the obtained trialkylsilylated carboxylate monomers and their use in antifouling coatings | SIGMA COATINGS B.V. (NL) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002094838-A1 | PROCESS FOR THE PREPARATION OF TRIALKYLSILYLATED CARBOXYLATE MONOMERS, THE OBTAINED TRIALKYLSILYLATED CARBOXYLATE MONOMERS AND THEIR USE IN ANTI-FOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2002-11-28 | — | — | WO | disclosed |
| EP-1260513-A1 | Process for the preparation of trialkylsilylated carboxylate monomers, the obtained trialkylsilylated carboxylate monomers and their use in antifouling coatings | SIGMA COATINGS B.V. (NL) | 2002-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236130-A1 | Process for the preparation of trialkylsilated carboxylate monomers, the obatined trialkylsilated carboxylate monomers and their use in anti-fouling coatings | ACMSD, OR10J3, CFD | TSHR 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.